KN713

KN713 · New Cancer Cure-Bio Co.,Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for KN713, covering 2025-01-08 to 2025-01-08. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of KN510, KN713 [Phase 1]